Overview 20 Week Bridging Study in Type II DM Status: Completed Trial end date: 2004-04-01 Target enrollment: Participant gender: Summary A multicenter, non-comparative, one arm, open, phase III study to evaluate the efficacy and safety of insulin glargine on subjects with Type 2 Diabetes Mellitus Phase: Phase 3 Details Lead Sponsor: SanofiTreatments: InsulinInsulin GlargineInsulin, Globin Zinc